The revised fourth edition of Evidence-Based Gastroenterology and Hepatology continues to provide the most current, evidence-based information for determining the appropriate medical and surgical options for screening for, diagnosing, and treating gastrointestinal conditions. With contributions from an international team of leading experts in the field, the 4th edition includes practical recommendations for the care of individual patients based on the latest scientific evidence.
Table of contents
Contributors xi
Preface xix
Part I Gastrointestinal disorders
1 Gastroesophageal reflux disease 3
Sabine Roman and Peter J. Kahrilas
2 Barrett’s esophagus 21
Anh D. Nguyen, Stuart J. Spechler, and Kerry B. Dunbar
3 Esophageal motility disorders 35
Gabriel Lang, C. Prakash Gyawali, and Peter J. Kahrilas
4 Eosinophilic esophagitis 50
Craig C. Reed and Evan S. Dellon
5 Ulcer disease and Helicobacter pylori infection: current treatment 68
Naoki Chiba
6 Nonsteroidal anti-inflammatory drug-gastropathy and enteropathy 86
Moe H. Kyaw, Alaa Rostom, Katherine Muir, Catherine Dubé, Emilie Jolicoeur, Michel Boucher, Peter Tugwell, George Wells, and Francis K.L. Chan
7 Acute non-variceal gastrointestinal hemorrhage: treatment 110
Kathryn Oakland and Vipul Jairath
8 Functional dyspepsia 127
Sander Veldhuyzen van Zanten
9 Celiac disease: diagnosis, screening, and prognosis 139
Adam S. Faye and Benjamin Lebwohl
10 Therapy for Crohn’s disease 150
Reena Khanna, Barrett G. Levesque, John W.D. McDonald, and Brian G. Feagan
11 Ulcerative colitis 173
Vipul Jairath, John W.D. McDonald, and Brian G. Feagan
12 Pouchitis after restorative proctocolectomy 187
Mathurin Fumery, Siddharth Singh, Darrell S. Pardi, and William J. Sandborn
13 Microscopic colitis: collagenous and lymphocytic colitis 196
Johan Bohr, Fernando Fernández-Bañares, and Ole K. Bonderup
14 Drug-induced diarrhea 208
Bincy P. Abraham, and Joseph H. Sellin
15 Prevention and treatment of travelers’ diarrhea 225
David R. Tribble
16 Metabolic bone disease in gastrointestinal disorders 240
Herman Bami, Arthur N. Lau, and Jonathan D. Adachi
17 Colorectal cancer in ulcerative colitis: surveillance 258
Paul Collins, Bret A. Lashner, and Alastair J.M. Watson
18 Colorectal cancer: population screening and surveillance 271
Catherine Dub´e and Linda Rabeneck
19 Clostridium difficile infections: epidemiology, diagnosis, and treatment 284
Lynne V. McFarland, Christina M. Surawicz, and Stephen M. Vindigni
20 Irritable bowel syndrome 306
Alexander C. Ford
21 Intestinal pseudo-obstruction (Ogilvie’s syndrome) 332
Meihuan Chang and Alexander G. Heriot
22 Gallstone disease 342
Kurinchi S. Gurusamy and Brian R. Davidson
23 Acute pancreatitis 353
Kurinchi S. Gurusamy and Brian R. Davidson
Part II Liver disease
24 Acute-on-chronic liver failure: diagnosis, prognosis, and treatment 363
Jane Macnaughtan
25 Acute liver failure: prognosis and management 374
Jennifer Price, Brian J. Hogan, and Banwari Agarwal
26 Infection in cirrhosis 384
Elisa Brauns and Thierry Gustot
27 Liver biopsy 395
Benjamin H. Mullish, Naveenta Kumar, Robert D. Goldin, and Pinelopi Manousou
28 Pregnancy and liver disease 408
J.J. King and R.H. Westbrook
29 Cholangiocarcinoma 425
Peter L. Labib, Giuseppe K. Fusai, and Stephen P. Pereira
30 Noninvasive tests of liver fibrosis 445
Laurent Castera
31 Hepatitis C: treatment 454
Mary D. Cannon, Kosh Agarwal, and Geoffrey Dusheiko
32 Hepatitis C virus (HCV) infection: in special situations 470
Eleni Koukoulioti and Thomas Berg
33 Hepatitis B: prognosis and treatment 490
Apostolos Koffas, Upkar Gill, and Patrick Kennedy
34 Alcoholic liver disease, 503
Meritxell Ventura-Cots, Nambi Ndugga, and Ramon Bataller
35 Nonalcoholic fatty liver disease 523
Marie Boyle and Quentin M. Anstee
36 Hemochromatosis 547
Gary P. Jeffrey and Paul C. Adams
37 Wilson’s disease 554
Claire Kelly, Aftab Ala, and Michael L. Schilsky
38 Primary biliary cholangitis (formerly primary biliary cirrhosis) 574
Palak J. Trivedi and Gideon M. Hirschfield
39 Autoimmune hepatitis 592
Martha M. Kirstein, Arndt Vogel, and Michael P. Manns
40 Primary sclerosing cholangitis 602
Mette Vesterhus and Tom H. Karlsen
41 Variceal bleeding 619
Damien Leith and Rajeshwar P. Mookerjee
42 Hepatic venous outflow syndromes and splanchnic venous thrombosis 645
Laure Elkrief and Dominique Valla
43 Ascites, hyponatremia, spontaneous bacterial peritonitis, and hepatorenal syndrome 662
Salvatore Piano, Marta Tonon, and Paolo Angeli
44 Hepatic encephalopathy: classification, diagnosis, and treatment 676
Radha K. Dhiman and Sahaj Rathi
45 Hepatocellular carcinoma: diagnosis and prognosis 693
Massimo Colombo and Massimo Iavarone
46 Hepatocellular carcinoma: treatment 703
Alexa Childs and Tim Meyer
47 Drug-induced liver disease: mechanism and diagnosis 715
Camilla Stephens, M. Isabel Lucena, and Raúl J. Andrade
48 Liver transplantation: prevention and treatment of rejection 729
François Durand and Claire Francoz
49 Liver transplantation: prevention and treatment of infection 744
Marta Bodro, Javier Fernández, and Asunción Moreno
50 Management of HCV infection after liver transplantation 753
Audrey Coilly, Bruno Roche, and Didier Samuel
Index
John W.D. McDonald, Professor of Medicine, Robarts Clinical Trials, Western University, London, Ontario, Canada.
Brian G. Feagan, Professor of Medicine and Epidemiology and Biostatistics, Robarts Clinical Trials, Robarts Research Unit, Western University, London, Ontario, Canada.
Rajiv Jalan, Professor of Hepatology and Head, Liver Failure Group, University College London, London, UK.
Peter J. Kahrilas, Professor of Medicine, Division of Gastroenterology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.
Onze klantenservice staat voor je klaar. Raadpleeg onze veelgestelde vragen of neem contact op.
Registreer je om een Acco-aandeel aan te kopen of te koppelen en geniet meteen van korting. Inloggen/registreren is ook nodig om bepaalde bestanden te downloaden.
Registreer